MUREX BIOTECH LIMITED

02670649
Active Maidenhead

Other manufacturing n.e.c.

0 employees website.com
Other manufacturing n.e.c.
M

MUREX BIOTECH LIMITED

02670649

Other manufacturing n.e.c.

Founded 12 Dec 1991 Active Maidenhead, United Kingdom 0 employees website.com
Other manufacturing n.e.c.

Previous Company Names

MUREX DIAGNOSTICS BRANCHES LIMITED 5 May 1992 — 1 Feb 1996
BCW BRANCHES LIMITED 13 Jan 1992 — 5 May 1992
ALNERY NO. 1150 LIMITED 12 Dec 1991 — 13 Jan 1992
Accounts Submitted 5 Sept 2025 Next due 30 Sept 2026 3 months remaining
Confirmation Submitted 21 Nov 2025 Next due 30 Nov 2026 5 months remaining
Net assets £45M £2M 2023 year on year
Total assets £45M £2M 2023 year on year
Total Liabilities £435K £397K 2023 year on year
Charges 2
1 outstanding 1 satisfied

Contact & Details

Contact

Registered Address

Abbott House Vanwall Business Park Vanwall Road Maidenhead Berkshire SL6 4XE United Kingdom

Full company profile for MUREX BIOTECH LIMITED (02670649), an active company based in Maidenhead, United Kingdom. Incorporated 12 Dec 1991. Other manufacturing n.e.c.. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2023
Type full
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Balance Sheet & P&L (2014–2023)

Cash in Bank

N/A

Net Assets

£44.76M

Increased by £1.53M (+4%)

Total Liabilities

£435.00k

Increased by £397.00k (+1045%)

Turnover

N/A

Employees

N/A

Decreased by 1 (-100%)

Debt Ratio

1%

Financial History

Revenue, profit, EBITDA and key financial figures

2023
31 Dec Year End
2022
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (1)

Abbott Laboratories Limited
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active
Active
Notified 6 Apr 2016
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

MUREX BIOTECH LIMITED Current Company

Charges

Charges

1 outstanding 1 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
15 Dec 2025OfficersTermination of Alison Elizabeth Davies as director on 10 Dec 2025
15 Dec 2025OfficersAppointment of Mr James Wenner as director on 10 Dec 2025
21 Nov 2025Confirmation StatementConfirmation statement made on 16 Nov 2025 with no updates
5 Sept 2025AccountsAnnual accounts made up to 31 Dec 2024
1 May 2025OfficersAppointment of Mr Ross Iain Campbell as director on 25 Apr 2025
15 Dec 2025 Officers

Termination of Alison Elizabeth Davies as director on 10 Dec 2025

15 Dec 2025 Officers

Appointment of Mr James Wenner as director on 10 Dec 2025

21 Nov 2025 Confirmation Statement

Confirmation statement made on 16 Nov 2025 with no updates

5 Sept 2025 Accounts

Annual accounts made up to 31 Dec 2024

1 May 2025 Officers

Appointment of Mr Ross Iain Campbell as director on 25 Apr 2025

Recent Activity

Latest Activity

Termination of Alison Elizabeth Davies as director on 10 Dec 2025

6 months ago on 15 Dec 2025

Appointment of Mr James Wenner as director on 10 Dec 2025

6 months ago on 15 Dec 2025

Confirmation statement made on 16 Nov 2025 with no updates

7 months ago on 21 Nov 2025

Annual accounts made up to 31 Dec 2024

9 months ago on 5 Sept 2025

Appointment of Mr Ross Iain Campbell as director on 25 Apr 2025

1 years ago on 1 May 2025